{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:32:15Z","timestamp":1794047535079,"version":"4.8.0"},"reference-count":60,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Von Willebrand disease (VWD) is a highly heterogeneous inherited bleeding disorder caused by reduced levels or activity of von Willebrand factor (VWF). VWD is associated with a wide spectrum of clinical and laboratory phenotypes, but diagnosis is based on three main criteria: a positive bleeding history, low levels of circulating VWF and autosomal inheritance patterns. VWD is classified into quantitative VWF deficiencies (type 1, partial and type 3, almost total) and peculiar qualitative defects (type 2 A, B, M, and N). The prevalence of VWD has been estimated by epidemiological investigations to be ~1%, but a clearcut diagnosis in clinical practice is often not possible because of several confounding factors influencing plasma VWF levels, especially in mild cases. The prevalence of clinically relevant VWD could range from 1\/1,000-10,000 inhabitants based on patients referred to tertiary care centers. Recent genetic prevalence data however suggest that pathogenic VWF variants or putative disease alleles may be significantly more common than 1%.<\/jats:p>","DOI":"10.3324\/haematol.2024.286058","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T19:57:17Z","timestamp":1767297437000},"page":"26-34","source":"Crossref","is-referenced-by-count":10,"title":["Von Willebrand disease: classification and epidemiology"],"prefix":"10.3324","volume":"111","author":[{"given":"Giancarlo","family":"Castaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Bramante Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"83158","unstructured":"von Willebrand EA. Heredit\u00e4r pseudohemofili. Finska L\u00e4kars\u00e4llskapets Handl. 1926; 67:7-112."},{"key":"83159","doi-asserted-by":"crossref","unstructured":"Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand\u2019s disease. Blood. 1987; 69(2):454-459.","DOI":"10.1182\/blood.V69.2.454.454"},{"key":"83160","doi-asserted-by":"crossref","unstructured":"Higham JM, O\u2019Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990; 97(8):734-739.","DOI":"10.1111\/j.1471-0528.1990.tb16249.x"},{"key":"83161","doi-asserted-by":"crossref","unstructured":"Friberg B, Orno AK, Lindgren A, Lethagen S. Bleeding disorders among young women: a population-based prevalence study. Acta Obstet Gynecol Scand. 2006; 85(2):200-206.","DOI":"10.1080\/00016340500342912"},{"key":"83162","doi-asserted-by":"crossref","unstructured":"Hedlund-Treutiger I, Revel-Vilk S, Blanchette VS, Curtin JA, Lillicrap D, Rand ML. Reliability and reproducibility of classification of children as \u201cbleeders\u201d versus \u201cnon-bleeders\u201d using a questionnaire for significant mucocutaneous bleeding. J Pediatr Hematol Oncol. 2004; 26(8):488-491.","DOI":"10.1097\/01.mph.0000133600.42259.c6"},{"key":"83163","doi-asserted-by":"crossref","unstructured":"Rodeghiero F, Castaman G, Tosetto A. The discriminant power of bleeding history for the diagnosis of von Willebrand disease type 1: an international, multicenter study. J Thromb Haemost. 2005; 3(12):2619-2626.","DOI":"10.1111\/j.1538-7836.2005.01663.x"},{"key":"83164","doi-asserted-by":"crossref","unstructured":"Sadler JE, Budde U, Eikenboom JC. Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006; 4(10):2103-2114.","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"83165","doi-asserted-by":"crossref","unstructured":"Leebeek FW, Eikenboom JC. Von Willebrand\u2019s disease. N Engl J Med. 2016; 375(21):2067-2080.","DOI":"10.1056\/NEJMra1601561"},{"key":"83166","doi-asserted-by":"crossref","unstructured":"Goodeve A, Eikenboom J, Castaman G. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood. 2007; 109(1):112-121.","DOI":"10.1182\/blood-2006-05-020784"},{"key":"83167","doi-asserted-by":"crossref","unstructured":"James PD, Paterson AD, Notley C. Association of Hemophilia Clinic Directors of Canada. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study. J Thromb Haemost. 2006; 4(4):783-792.","DOI":"10.1111\/j.1538-7836.2006.01860.x"},{"key":"83168","doi-asserted-by":"crossref","unstructured":"Eikenboom JC, Reitsma PH, Peerlinck KM, Bri\u00ebt E. Recessive inheritance of von Willebrand\u2019s disease type I. Lancet. 1993; 341(8851):982-986.","DOI":"10.1016\/0140-6736(93)91070-3"},{"key":"83169","doi-asserted-by":"crossref","unstructured":"Lavin M, Aguila S, Schneppenheim S. Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels. Blood. 2017; 130(21):2344-2353.","DOI":"10.1182\/blood-2017-05-786699"},{"key":"83170","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell JS, Baker RI, Atiq F. Low von Willebrand factor-unraveling an enigma wrapped in a conundrum. J Thromb Haemost. 2024; 22(12):3383-3388.","DOI":"10.1016\/j.jtha.2024.08.015"},{"key":"83171","doi-asserted-by":"crossref","unstructured":"James PD, Connell NT, Ameer B. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021; 5(1):280-300.","DOI":"10.1182\/bloodadvances.2020003265"},{"key":"83172","doi-asserted-by":"crossref","unstructured":"Seidizadeh O, Eikenboom JCJ, Denis CV. von Willebrand disease. Nat Rev Dis Primers. 2024; 10(1):51.","DOI":"10.1038\/s41572-024-00536-8"},{"key":"83173","doi-asserted-by":"crossref","unstructured":"Castaman G, Goodeve A, Eikenboom JC, on behalf of the European Group on von Willebrand disease (EUVWD). Principles of care for diagnosis and treatment of von Willebrand disease. Haematologica. 2013; 98(5):667-674.","DOI":"10.3324\/haematol.2012.077263"},{"key":"83174","doi-asserted-by":"crossref","unstructured":"De Wee EM, Sanders YV, Mauser-Bunschoten EP. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease. Thromb Haemost. 2012; 108(4):683-692.","DOI":"10.1160\/TH12-04-0244"},{"key":"83175","doi-asserted-by":"crossref","unstructured":"Castaman G, James PD. Pregnancy and delivery in women with von Willebrand disease. Eur J Haematol. 2019; 103(2):73-79.","DOI":"10.1111\/ejh.13250"},{"key":"83176","doi-asserted-by":"crossref","unstructured":"De Wee EM, Knol HM, Mauser-Bunschoten EP. Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease. Thromb Haemost. 2011; 106(5):885-892.","DOI":"10.1160\/TH11-03-0180"},{"key":"83177","doi-asserted-by":"crossref","unstructured":"Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998; 351(9101):485-489.","DOI":"10.1016\/S0140-6736(97)08248-2"},{"key":"83178","doi-asserted-by":"crossref","unstructured":"Dupervil B, Abe K, O\u2019Brien SH. Characteristics, complications, and sites of bleeding among infants and toddlers less than 2 years of age with VWD. Blood Adv. 2021; 5(8):2079-2086.","DOI":"10.1182\/bloodadvances.2020004141"},{"key":"83179","doi-asserted-by":"crossref","unstructured":"Castaman G, Tosetto A, Federici AB, Rodeghiero F. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance. Thromb Haemost. 2011; 105(4):647-654.","DOI":"10.1160\/TH10-11-0697"},{"key":"83180","doi-asserted-by":"crossref","unstructured":"van Galen KP, Mauser-Bunschoten EP, Leebeek FW. Hemophilic arthropathy in patients with von Willebrand disease. Blood Rev. 2012; 26(6):261-266.","DOI":"10.1016\/j.blre.2012.09.002"},{"key":"83181","doi-asserted-by":"crossref","unstructured":"Tosetto A, Badiee Z, Baghaipour MR. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: results from 3WINTERS-IPS, an international and collaborative cross-sectional study. J Thromb Haemost. 2020; 18(9):2145-2154.","DOI":"10.1111\/jth.14886"},{"key":"83182","doi-asserted-by":"crossref","unstructured":"Castaman G, Federici AB, Tosetto A. Different bleeding risk in type 2 A and 2 M von Willebrand disease: a two-year prospective study in 107 patients. J Thromb Haemost. 2012; 10(4):632-638.","DOI":"10.1111\/j.1538-7836.2012.04661.x"},{"key":"83183","doi-asserted-by":"crossref","unstructured":"Federici AB, Bucciarelli P, Castaman G. The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease. Blood. 2014; 123(26):4037-4044.","DOI":"10.1182\/blood-2014-02-557264"},{"key":"83184","doi-asserted-by":"crossref","unstructured":"Leebeek FWG, Duvekot J, Kruip MJHA. How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease. Blood. 2020; 136(19):2143-2150.","DOI":"10.1182\/blood.2019000964"},{"key":"83185","doi-asserted-by":"crossref","unstructured":"Tosetto A, Rodeghiero F, Castaman G. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost. 2006; 4(4):766-773.","DOI":"10.1111\/j.1538-7836.2006.01847.x"},{"key":"83186","doi-asserted-by":"crossref","unstructured":"Wahlberg T, Blomback M, Hall P, Axelsson G. Application of indicators, predictors and diagnostic indices in coagulation disorders. I. Evaluation of a self-administered questionnaire with binary questions. Methods Inf Med. 1980; 19(4):194-200.","DOI":"10.1055\/s-0038-1635279"},{"key":"83187","doi-asserted-by":"crossref","unstructured":"Sramek A, Eikenboom JC, Briet E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Intern Med. 1995; 155(13):1409-1415.","DOI":"10.1001\/archinte.1995.00430130095010"},{"key":"83188","doi-asserted-by":"crossref","unstructured":"Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost. 1988; 59(3):349-352.","DOI":"10.1055\/s-0038-1647493"},{"key":"83189","doi-asserted-by":"crossref","unstructured":"Rodeghiero F, Tosetto A, Abshire T. ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders: ISTH\/ SSC bleeding assessment tool. J Thromb Haemost. 2010; 8(9):2063-2065.","DOI":"10.1111\/j.1538-7836.2010.03975.x"},{"key":"83190","doi-asserted-by":"crossref","unstructured":"Eikenboom J, Van Marion V, Putter H. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost. 2006; 4(4):774-782.","DOI":"10.1111\/j.1538-7836.2006.01823.x"},{"key":"83191","doi-asserted-by":"crossref","unstructured":"Castaman G, Eikenboom JCJ, Bertina R, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiologic investigation. Thromb Haemost. 1999; 82(3):1065-1070.","DOI":"10.1055\/s-0037-1614330"},{"key":"83192","doi-asserted-by":"crossref","unstructured":"Tosetto A, Castaman G, Rodeghiero F. Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach. Blood. 2008; 111(8):3998-4003.","DOI":"10.1182\/blood-2007-08-105940"},{"key":"83193","doi-asserted-by":"crossref","unstructured":"Weiss HJ, Ball AP, Mannucci PM. Incidence of severe von Willebrand\u2019s disease. N Engl J Med. 1982; 307(2):127.","DOI":"10.1056\/NEJM198207083070221"},{"key":"83194","doi-asserted-by":"crossref","unstructured":"Mannucci PM, Bloom AL, Larrieu MJ, Nilsson IM, West RR. Atherosclerosis and von Willebrand factor. I. Prevalence of severe von Willebrand\u2019s disease in Western Europe and Israel. Br J Haematol. 1984; 57(1):163-169.","DOI":"10.1111\/j.1365-2141.1984.tb02876.x"},{"key":"83195","doi-asserted-by":"crossref","unstructured":"Berliner SA, Seligsohn U, Zivelin A, Zwang E, Sofferman G. A relatively high frequency of severe (type III) von Willebrand\u2019s disease in Israel. Br J Haematol. 1986; 62(3):535-543.","DOI":"10.1111\/j.1365-2141.1986.tb02966.x"},{"key":"83196","doi-asserted-by":"crossref","unstructured":"Nilsson IM. In memory of Erik Jorpes. von Willebrand\u2019s disease from 1926-1983. Scand J Haematol Suppl. 1984; 40:21-43.","DOI":"10.1111\/j.1600-0609.1984.tb02543.x"},{"key":"83197","unstructured":"Bloom AL, Giddins JC. HIV infection and AIDS in von Willebrand\u2019s disease. An international survey including data on the prevalence of clinical von Willebrand\u2019s disease. 1991;405-411."},{"key":"83198","doi-asserted-by":"crossref","unstructured":"Bloom AL. The von Willebrand syndrome. Semin Hematol. 1980; 17(4):215-227.","DOI":"10.1016\/0049-3848(80)90308-4"},{"key":"83199","unstructured":"Bachman F. Diagnostic approach to mild bleeding disorders. Semin Hematol. 1980; 17(4):292-312."},{"key":"83200","doi-asserted-by":"crossref","unstructured":"Sadler JE, Mannucci PM, Berntorp E. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000; 84(2):160-174.","DOI":"10.1055\/s-0037-1613992"},{"key":"83201","doi-asserted-by":"crossref","unstructured":"Werner EJ, Broxson EH, Tucker EL. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediat. 1993; 123(6):893-898.","DOI":"10.1016\/S0022-3476(05)80384-1"},{"key":"83202","doi-asserted-by":"crossref","unstructured":"Miller CH, Lenzi R, Breen C. Prevalence of von Willebrand\u2019s disease among U.S. adults. Blood. 1987; 70(Suppl. 1):377.","DOI":"10.1182\/blood.V70.6.1804.bloodjournal7061804"},{"key":"83203","unstructured":"Meriane F, Sultan Y, Arabi H. Incidence of a low von Willebrand factor activity in a population of Algerian students. Blood. 1991; 78(Suppl. 1):484."},{"key":"83204","doi-asserted-by":"crossref","unstructured":"Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand\u2019s disease. I. Phenotypic variation within families. Blood. 1979; 54(1):117-136.","DOI":"10.1182\/blood.V54.1.117.bloodjournal541117"},{"key":"83205","doi-asserted-by":"crossref","unstructured":"Abu-Douleh E, Al-Numair N, Albanyan A, Alsuliman A, Bayoumi N, Owaidah T. Prevalence of von Willebrand disease among university students in Riyadh, Saudi Arabia. J Appl Hematol. 2018; 9(4):136-139.","DOI":"10.4103\/joah.joah_63_18"},{"key":"83206","doi-asserted-by":"crossref","unstructured":"Bowman M, Hopman WM, Rapson D, Lillicrap D, James P. The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost. 2010; 8(1):213-216.","DOI":"10.1111\/j.1538-7836.2009.03661.x"},{"key":"83207","doi-asserted-by":"crossref","unstructured":"Bowman M, Hopman WM, Rapson D, Lillicrap D, Silva M, James P. A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population. Pediatr Blood Cancer. 2010; 55(1):171-173.","DOI":"10.1002\/pbc.22429"},{"key":"83208","doi-asserted-by":"crossref","unstructured":"Stonebraker JS, Iorio A, Lavin M. Reported prevalence of von Willebrand disease worldwide in relation to income classification. Haemophilia. 2023; 29(4):975-986.","DOI":"10.1111\/hae.14810"},{"key":"83209","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan JM, Tootoonchian E, Ziemele B. von Willebrand disease: gaining a global perspective. Haemophilia. 2023; 29(4):1104-1112.","DOI":"10.1111\/hae.14804"},{"key":"83210","doi-asserted-by":"crossref","unstructured":"Castaman G, Eikenboom JC, Missiaglia E, Rodeghiero F. Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect. Br J Haematol. 2000; 108(4):876-879.","DOI":"10.1046\/j.1365-2141.2000.01944.x"},{"key":"83211","doi-asserted-by":"crossref","unstructured":"Goodeve AC. The genetic basis of von Willebrand disease. Blood Rev. 2010; 24(3):123-134.","DOI":"10.1016\/j.blre.2010.03.003"},{"key":"83212","doi-asserted-by":"crossref","unstructured":"Castaman G, Rodeghiero F, Tosetto A. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study. J Thromb Haemost. 2006; 4(10):2164-2169.","DOI":"10.1111\/j.1538-7836.2006.02070.x"},{"key":"83213","doi-asserted-by":"crossref","unstructured":"Castaman G, Bertoncello K, Bernardi M, Eikenboom JC, Budde U, Rodeghiero F. Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutation. Am J Hematol. 2007; 82(5):376-380.","DOI":"10.1002\/ajh.20803"},{"key":"83214","doi-asserted-by":"crossref","unstructured":"Castaman G, Giacomelli S, Rodeghiero F. Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families. Acta Haematol. 2009; 121(2-3):106-110.","DOI":"10.1159\/000214850"},{"key":"83215","doi-asserted-by":"crossref","unstructured":"Seidizadeh O, Cairo A, Baronciani L, Valenti L, Peyvandi F. Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases. NPJ Genom Med. 2023; 8(1):31.","DOI":"10.1038\/s41525-023-00375-8"},{"key":"83216","doi-asserted-by":"crossref","unstructured":"Seidizadeh O, Cairo A, Oriani C, Peyvandi F. Global prevalence and ethnic diversity of von Willebrand disease: an updated population-based genetic analysis. May 25. 2025.","DOI":"10.21203\/rs.3.rs-6577209\/v1"},{"key":"83217","doi-asserted-by":"crossref","unstructured":"Rodeghiero F. von Willebrand disease: still an intriguing disorder in the era of molecular medicine. Haemophilia. 2002; 8(3):292-300.","DOI":"10.1046\/j.1365-2516.2002.00611.x"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.286058\/79196","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.286058\/79258","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/13054\/79196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:10:44Z","timestamp":1794046244000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.286058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.286058","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}